Several abstracts, including a late-breaking podium presentation and posters, bring forward accumulating long-term efficacy, safety and caregiver-reported insights that deepen understanding of ...

Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases ...

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, will present at the Muscular Dystrophy Association (MDA) Clinical & Scientific Conference, taking ...

Roche’s autoimmune drug Enspryng is making solid progress as a treatment for neuromyelitis optica spectrum disorder (NMOSD). But the company’s efforts to expand its use to a new indication is coming ...

– CIRRUS-HCM 12-week data of EDG-7500 in obstructive and nonobstructive hypertrophic cardiomyopathy (HCM) expected in H1 2026 – – Phase 1 healthy adult trial data of EDG-15400 and plans for heart ...

Keros Therapeutics KROS is focused on developing and commercializing novel therapeutics to treat a wide range of patients ...

Reported Promising Data for TN-201 and TN-401 Gene Therapies in Fourth Quarter of 2025; Additional Data Readouts and Pursuit of Regulatory ...

Determined Stoke City fan Paul Parsons has been clocking up the miles as he looks to score for charity after being inspired by his friend's brave daughter. The 46-year-old had this week set off from ...

Dr. Oster is the founder and chief executive of ParentData and a professor of economics at Brown University. February is the month things go south in our exercise routines. The excitement of New ...

ON THIS PAGEPhysical Therapy vs. General ExerciseEssential LEMS ExercisesAssistive Tools and Home ModificationsIf youre living with Lambert-Eaton myasthenic syndrome (LEMS), you may notice that your ...